HistoSonics Gets FDA Nod for Breakthrough Device That Destroys Liver Tumors

HistoSonics’ Edison System, which uses focused ultrasound to mechanically destroy and liquify unwanted liver tissue and tumors, has received de novo marketing authorization from the FDA and is the first histotripsy platform available in the U.S.
Source: Drug Industry Daily